Ads
related to: prostate antigen wikipedia- Diagnosis Information
Info On Prostate Cancer Diagnosis.
Read About Advanced Prostate Cancer
- PSMA Biomarker Info
Learn About PSMA Biomarker.
Info For Metastatic Prostate Cancer
- Patient Resources
Navigating Your Prostate Cancer.
Info For Advanced Prostate Cancer.
- Info About Your Condition
Read About Advanced Prostate Cancer
Discover Information For Patients.
- Diagnosis Information
Search results
Results From The WOW.Com Content Network
Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), P-30 antigen, is a glycoprotein enzyme encoded in humans by the KLK3 gene.PSA is a member of the kallikrein-related peptidase family and is secreted by the epithelial cells of the prostate gland in men and the paraurethral glands in women.
TAH molecule, also known as N-acetyl-L-aspartyl-L-glutamate peptidase I (NAALADase I), NAAG peptidase, or prostate-specific membrane antigen (PSMA) is an enzyme that in humans is encoded by the FOLH1 (folate hydrolase 1) gene. [5] Human GCPII contains 750 amino acids and weighs approximately 84 kDa. [6]
Prostate-specific antigen. Prostate-specific antigen (PSA) is secreted by the epithelial cells of the prostate gland and can be detected in a sample of blood. [14] PSA is present in small quantities in the serum of men with healthy prostates, but is often elevated in the presence of prostate cancer or other prostate disorders. [15]
Prostate cancer is the uncontrolled growth of cells in the prostate, a gland in the male reproductive system below the bladder. Abnormal growth of prostate tissue is usually detected through screening tests, typically blood tests that check for prostate-specific antigen (PSA) levels. Those with high levels of PSA in their blood are at increased ...
Richard J. Ablin (May 15, 1940 – October 6, 2023) [1] was an American scientist, most notable for research on prostate cancer.According to the Wall Street Journal: . Richard Ablin, a professor of pathology at University of Arizona College of Medicine, discovered the prostate-specific antigen (PSA) in 1970, and for nearly as long, he has argued that it should not be used for routine screening.
Although prostate specific antigen levels may be elevated in males with BPH, the condition does not increase the risk of prostate cancer. [8] The prevalence of enlarged prostate, and symptoms of an enlarged prostate, in men of different ages. [9] [10] Graphic from NHS England. [11]
Ad
related to: prostate antigen wikipedia